Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2022 Earnings Call Transcript

Anna Marie Wagner: Good afternoon. This is Anna Marie Wagner, SVP of Corporate Development at Ginkgo Bioworks.

Keep Reading →